Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals
Clinical trial NCT05788185 · TERMINATED
Trial details
- NCT number
- NCT05788185
- Sponsor
- RVAC Medicines (US), Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-22
- Primary completion
- 2023-09-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.